Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker SLDB
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | Gabriel Brooks Chief Medical Officer | SLDB Solid Biosciences Inc. | Sale | 4,374 | $5.62 | $24.6K Sale | Form 4 ↗ |
| Feb 18, 2026 | Alexander Cumbo President and CEO, Director | SLDB Solid Biosciences Inc. | Sale | 16,644 | $5.82 | $96.9K Sale | Form 4 ↗ |
| Feb 18, 2026 | Jessie Hanrahan Chief Regulatory Officer | SLDB Solid Biosciences Inc. | Sale | 4,134 | $5.82 | $24.1K Sale | Form 4 ↗ |
| Feb 18, 2026 | Ilan Ganot Director | SLDB Solid Biosciences Inc. | Sale | 2,658 | $5.82 | $15.5K Sale | Form 4 ↗ |
| Feb 18, 2026 | Paul Herzich Chief Technology Officer | SLDB Solid Biosciences Inc. | Sale | 3,616 | $5.82 | $21.0K Sale | Form 4 ↗ |
| Feb 18, 2026 | David T. Howton Chief Operating Officer | SLDB Solid Biosciences Inc. | Sale | 7,469 | $5.82 | $43.5K Sale | Form 4 ↗ |
| Feb 18, 2026 | Gabriel Brooks Chief Medical Officer | SLDB Solid Biosciences Inc. | Sale | 0 | $5.82 | $0 Sale | Form 4 ↗ |
| Feb 18, 2026 | Kevin Tan CFO & Treasurer | SLDB Solid Biosciences Inc. | Sale | 5,404 | $5.82 | $31.5K Sale | Form 4 ↗ |
| Feb 4, 2026 | David T. Howton Chief Operating Officer | SLDB Solid Biosciences Inc. | Sale | 18,894 | $6.44 | $121.7K Sale | Form 4 ↗ |
| Feb 4, 2026 | Alexander Cumbo President and CEO, Director | SLDB Solid Biosciences Inc. | Sale | 48,913 | $6.44 | $315.0K Sale | Form 4 ↗ |
| Feb 4, 2026 | Ilan Ganot Director | SLDB Solid Biosciences Inc. | Sale | 7,205 | $6.44 | $46.4K Sale | Form 4 ↗ |
| Feb 4, 2026 | Kevin Tan CFO & Treasurer | SLDB Solid Biosciences Inc. | Sale | 14,783 | $6.44 | $95.2K Sale | Form 4 ↗ |
| Feb 4, 2026 | Gabriel Brooks Chief Medical Officer | SLDB Solid Biosciences Inc. | Sale | 12,616 | $6.44 | $81.2K Sale | Form 4 ↗ |
| Feb 4, 2026 | Jessie Hanrahan Chief Regulatory Officer | SLDB Solid Biosciences Inc. | Sale | 12,348 | $6.44 | $79.5K Sale | Form 4 ↗ |
| Feb 4, 2026 | Paul Herzich Chief Technology Officer | SLDB Solid Biosciences Inc. | Sale | 10,905 | $6.44 | $70.2K Sale | Form 4 ↗ |
| Feb 2, 2026 | Kevin Tan CFO & Treasurer | SLDB Solid Biosciences Inc. | Sale | 26,837 | $6.44 | $172.8K Sale | Form 4 ↗ |
| Feb 2, 2026 | Alexander Cumbo President and CEO, Director | SLDB Solid Biosciences Inc. | Sale | 80,258 | $6.44 | $516.9K Sale | Form 4 ↗ |
| Feb 2, 2026 | Jessie Hanrahan Chief Regulatory Officer | SLDB Solid Biosciences Inc. | Sale | 26,535 | $6.44 | $170.9K Sale | Form 4 ↗ |
| Feb 2, 2026 | Gabriel Brooks Chief Medical Officer | SLDB Solid Biosciences Inc. | Sale | 28,335 | $6.44 | $182.5K Sale | Form 4 ↗ |
| Feb 2, 2026 | David T. Howton Chief Operating Officer | SLDB Solid Biosciences Inc. | Sale | 37,771 | $6.44 | $243.2K Sale | Form 4 ↗ |
| Feb 2, 2026 | Paul Herzich Chief Technology Officer | SLDB Solid Biosciences Inc. | Sale | 26,250 | $6.44 | $169.1K Sale | Form 4 ↗ |
| Jan 28, 2026 | Ilan Ganot Director | SLDB Solid Biosciences Inc. | Sale | 191 | $6.59 | $1,259 Sale | Form 4 ↗ |
| Jan 13, 2026 | Kevin Tan CFO & Treasurer | SLDB Solid Biosciences Inc. | Sale | 5,704 | $5.27 | $30.1K Sale | Form 4 ↗ |
| Jan 5, 2026 | Ilan Ganot Director | SLDB Solid Biosciences Inc. | Sale | 1,053 | $5.43 | $5,718 Sale | Form 4 ↗ |
| Dec 3, 2025 | David T. Howton Chief Operating Officer | SLDB Solid Biosciences Inc. | Sale | 4,932 | $5.11 | $25.2K Sale | Form 4 ↗ |
| Dec 3, 2025 | Alexander Cumbo President and CEO, Director | SLDB Solid Biosciences Inc. | Sale | 10,808 | $5.11 | $55.2K Sale | Form 4 ↗ |
| Dec 3, 2025 | Jessie Hanrahan Chief Regulatory Officer | SLDB Solid Biosciences Inc. | Sale | 4,483 | $5.11 | $22.9K Sale | Form 4 ↗ |
| Dec 3, 2025 | Paul Herzich Chief Technology Officer | SLDB Solid Biosciences Inc. | Sale | 2,701 | $5.11 | $13.8K Sale | Form 4 ↗ |
| Nov 10, 2025 | Ilan Ganot Director | SLDB Solid Biosciences Inc. | Sale | 3,278 | $4.12 | $13.5K Sale | Form 4 ↗ |
| Oct 20, 2025 | Gabriel Brooks Chief Medical Officer | SLDB Solid Biosciences Inc. | Sale | 2,895 | $5.96 | $17.3K Sale | Form 4 ↗ |
| Mar 11, 2025 | Clare Kahn Director | SLDB Solid Biosciences Inc. | Buy | 1,860 | $5.34 | $9,932 Buy | Form 4 ↗ |
| Feb 19, 2025 | Joseph Edelman Director, 10% owner | SLDB Solid Biosciences Inc. | Buy | 5.00M | $4.03 | $20.1M Buy | Form 4 ↗ |
| Feb 19, 2025 | BCLS SB Investco, LP 10% owner | SLDB Solid Biosciences Inc. | Buy | 1.00M | $4.03 | $4.0M Buy | Form 4 ↗ |
| Feb 18, 2025 | Robert Atchinson 10% owner | SLDB Solid Biosciences Inc. | Buy | 252,545 | $7.56 | $1.9M Buy | Form 4 ↗ |
| Feb 14, 2025 | Jessie Hanrahan Chief Regulatory Officer | SLDB Solid Biosciences Inc. | Sale | 3,079 | $3.96 | $12.2K Sale | Form 4 ↗ |
| Feb 14, 2025 | Gabriel Brooks Chief Medical Officer | SLDB Solid Biosciences Inc. | Sale | 3,256 | $3.96 | $12.9K Sale | Form 4 ↗ |
| Feb 14, 2025 | Kevin Tan CFO & Treasurer | SLDB Solid Biosciences Inc. | Sale | 3,164 | $3.96 | $12.5K Sale | Form 4 ↗ |
| Feb 14, 2025 | Paul Herzich Chief Technology Officer | SLDB Solid Biosciences Inc. | Sale | 2,688 | $3.96 | $10.6K Sale | Form 4 ↗ |
| Feb 14, 2025 | Alexander Cumbo President and CEO, Director | SLDB Solid Biosciences Inc. | Sale | 11,365 | $3.96 | $45.0K Sale | Form 4 ↗ |
| Feb 14, 2025 | Ilan Ganot Director | SLDB Solid Biosciences Inc. | Sale | 1,711 | $3.96 | $6,776 Sale | Form 4 ↗ |
| Feb 14, 2025 | David T. Howton Chief Operating Officer | SLDB Solid Biosciences Inc. | Sale | 5,561 | $3.96 | $22.0K Sale | Form 4 ↗ |
| Jan 28, 2025 | Ilan Ganot Director | SLDB Solid Biosciences Inc. | Sale | 144 | $3.11 | $448 Sale | Form 4 ↗ |
| Jan 10, 2025 | Kevin Tan CFO & Treasurer | SLDB Solid Biosciences Inc. | Sale | 4,073 | $3.89 | $15.8K Sale | Form 4 ↗ |
| Jan 6, 2025 | Ilan Ganot Director | SLDB Solid Biosciences Inc. | Sale | 1,056 | $4.31 | $4,551 Sale | Form 4 ↗ |
| Dec 3, 2024 | Jessie Hanrahan Chief Regulatory Officer | SLDB Solid Biosciences Inc. | Sale | 4,610 | $5.60 | $25.8K Sale | Form 4 ↗ |
| Dec 3, 2024 | Alexander Cumbo President and CEO, Director | SLDB Solid Biosciences Inc. | Sale | 11,114 | $5.60 | $62.2K Sale | Form 4 ↗ |
| Dec 3, 2024 | David T. Howton Chief Operating Officer | SLDB Solid Biosciences Inc. | Sale | 5,072 | $5.60 | $28.4K Sale | Form 4 ↗ |
| Dec 3, 2024 | Paul Herzich Chief Technology Officer | SLDB Solid Biosciences Inc. | Sale | 2,777 | $5.60 | $15.6K Sale | Form 4 ↗ |
| Oct 21, 2024 | Gabriel Brooks Chief Medical Officer | SLDB Solid Biosciences Inc. | Sale | 2,923 | $6.50 | $19.0K Sale | Form 4 ↗ |
49 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:58 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances